Concentrix (NASDAQ:CNXC) reported modest Q2 growth with $2.46B revenue (+1.9% YoY), $2.63 adj. EPS, $347.4M adj. EBITDA and record operating cash flow, trimming net debt while guiding FY revenue ~$9.925–10.025B; analysts pared price targets amid mixed ratings.
Previous Week Recap
- Concentrix Q2 Revenue, Cash Flow: Concentrix (CNXC) Q2 FY2026: revenue $2.46B (+1.9% YoY), adj. EPS $2.63, adj. EBITDA $347.4M, record operating cash flow ~$257.9M, net debt down. FY revenue guide $9.925–10.025B; Q3 $2.465–2.49B.
- Analyst Price-Target Cuts: Analysts cut Concentrix (CNXC) price targets after recent results: BofA $26, Barrington $30, Baird $30, Canaccord $45; ratings ranged from Neutral to Buy.
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.